NX EQ Autotransfusion Units - BNOE

Solicitation Number:
36C10G18Q0168
Notice Type:
Combined Synopsis/Solicitation
Synopsis:
COMBINED SYNOPSIS/SOLICITATION
This is a combined synopsis/solicitation for Brand name or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
Solicitation number 36C10G18Q0168 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2005-97, dated 24 Jan 2018.
Requirement Description:
The Department of Veterans Affairs (VA) is transforming the service it provides to Veterans through the MyVA effort. MyVA was established in July 2015 to modernize the Department s culture, processes, and capabilities to put the needs, expectations and interests of Veterans and their families first. This effort is highly visible, with significant attention within the highest levels of government, the public, and the press.
As this transformation progresses, VA's mission requirements to support America s Veterans are growing more quickly than its budget. Key elements of VA s expanded mission requirements include:
15% expansion in the number of Veterans enrolled in VA Healthcare from FY 2009 through FY 2016.
More than 100% increase between FY 2009 and FY 2016 in the number of 100% disabled Veterans cared for by VA.
6% increase in the number of medical appointments scheduled in FY 2016 vs FY 2014.
More than 300% increase between FY 2009 and FY 2016 in the number of Veterans receiving education benefits through the VA.
In order to ensure we are able to continue to provide Veterans with the benefits and care they have earned through their selfless service, VA is changing the way we do business. Specifically, we are improving the management of our supply chain to aggregate demand and facilitate ease of ordering in the field. Throughout VA, we are moving from local contracting to national contracting whenever feasible. Simplified ordering processes will drive volume towards suppliers with national contracts. Simultaneously, greater cost transparency throughout the VA will allow clinicians and VA leaders to select medical equipment that optimizes Veteran outcomes at the lowest cost.
For our suppliers, we anticipate that these changes will ease the process of doing business with the VA and drive down our suppliers costs. We welcome opportunities to work closely with suppliers to further reduce costs. In return, we expect that suppliers will offer the VA value commensurate with VA s status as the largest integrated healthcare provider in the United States. Specifically, VA expects that it will receive the most favorable prices, warranties, conditions, benefits, and terms for the same product as those given by the supplier to any provider in the country. We expect that VA s large volumes will increasingly be directed toward those suppliers best able to offer value to the VA. VA looks forward to collaborating with its suppliers to further drive down costs in order to deliver optimal value to our Veterans.
In light of this transformation, the VA has a requirement to purchase Autotransfusion Units to deliver patient care at its VA Medical Centers around the country. Autotransfusion Units are designed to recover and deliver back a patient s own blood during medium to high blood loss surgical procedures. This particular type of Autotransfusion Unit is a foldable, portable, lightweight electrical unit on locking casters and is utilized in the operating room. A single-award Firm-Fixed Price Requirements contract will be awarded for the purchase of Brand Name or Equal equipment in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the Brand Name or Equal equipment. The Government reserves the right to award without discussions.
The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 Surgical and Medical Instrument Manufacturing and the associated size standard is 1,000 employees. This procurement action is issued full and open competition.
This acquisition is for a single-award Firm-Fixed Price Requirements contract in accordance with FAR Part 16.5 for Haemonetics® brand name or equal Autotransfusion Units and related equipment and accessories as identified in ATTACHMENT A - AUTOTRANSFUSION UNITS PRICE/COST SCHEDULE. All interested companies shall provide a quote for all Contract Line Item Numbers (CLINs) listed in ATTACHMENT A - AUTOTRANSFUSION UNITS PRICE/COST SCHEDULE.
The ordering period is for one year with two 12 month option years. Delivery is FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.
The FAR provision at 52.212-1, Instructions to Offerors Commercial, applies to this acquisition including attached addenda to the provision.
The FAR provision at 52.212-2, Evaluation -- Commercial Items, and the specific evaluation criteria as attached addenda also applies to this acquisition
The Offeror is to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Items, with its offer.
Clause at 52.212-4, Contract Terms and Conditions -- Commercial Items, applies to this acquisition and a statement regarding any addenda to the clause. Addendum is attached.
Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders -- Commercial Items, applies to this acquisition and a statement regarding which, if any, of the additional FAR clauses cited in the clause are applicable to the acquisition. Addendum is attached.
All interested Offerors must be registered in the System for Award Management (SAM) prior to receiving an award. You may access SAM at https://www.sam.gov/portal/public/SAM/.
Questions regarding this combined synopsis/solicitation are due via email by 2:00PM EST on August 7, 2018 to Ninatile.Bacote@va.gov. No calls will be accepted.
Quotes are due via email by 2:00PM EST on August 24, 2018 to Ninatile.Bacote@va.gov.
Salient Characteristics
Literature Review
Autotransfusion Units
SCOPE OF WORK:
The Veterans Health Administration (VHA) Equipment Life Cycle Management (ELCM) Program identified Autotransfusion Units as a candidate for VA-wide (otherwise referred to as national ) single award Requirements contract. Autotransfusion Units are designed to recover and deliver back a patient s own blood during medium to high blood loss surgical procedures. This particular type of Autotransfusion Unit is a foldable, portable, lightweight electrical unit on locking casters and is utilized in the operating room.
The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Autotransfusion Units to be used by clinicians throughout the VA medical centers and facilities. The period of performance is for one 12 month base period with two 12 month option periods.
REQUIREMENT
This requirement will be IAW FAR clause 52.211-6, Brand Name or Equal which requires that the quoter indicate each product that is being offered as an equal product to the Medtronic® brand of Autotransfusion Units. For each equal product, the quoter must include a description reflecting the characteristics and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The quoter also must clearly identify the item by brand name (if any) and make/model number. Finally, the quoter must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer, and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.
Autotransfusion Units
CLINS
Brand
Part Number
Description
0001
Haemonetics
00205-00
RESERVOIR, HARD-SHELL, 150u
0002
Haemonetics
00208-00
BASIC A & A ASSEMBLY,LN 208
0003
Haemonetics
00220-00
RESERVOIR, HARD-SHELL, 20U
0004
Haemonetics
00245-00
RBC BAG W/TWIST-LOCK CONNECTOR
0005
Haemonetics
CSE-B-1000
BAG ASSY, WASTE, 10L
0006
Haemonetics
CSE-FP-125V
CE ELITE FASTPACK,125mL,150u
0007
Haemonetics
CSE-FP-225V
CS ELITE FASTPACK,225ML,150U
0008
Haemonetics
CSE-P-125
CS ELITE PROCESSING KIT, 125ML
0009
Haemonetics
CSE-P-225
CS ELITE PROCESSING KIT, 225ML
0010
Haemonetics
CSE-P-70
CS ELITE PROCESSING KIT, 70ML
0011
Haemonetics
CSE-SQ-1000
SEQUESTRATION KIT, CSE-SQ-1000
0012
Haemonetics
HAR-A-1000
VACUUM LINE, FILTERED
0013
Haemonetics
HAR-A-1003
ASPIRATION & ANTICOAG LINE
0014
Haemonetics
01500-00
ORTHOPAT POST-OP LINE
0015
Haemonetics
01550-00
ORTHOPAT EXTENDED POST-OP LINE
0016
Haemonetics
CSE-EW-US
CELL SAVER ELITE PLUS, US
SC
APPLICABLE CLINs
SALIENT CHARACTERISTICS
METHOD OF EVALUATION
SC 1
0016
System provides patients with their own washed blood
Literature Review
SC 2
0016
System must have fat reduction protocol and offer custom settings that allow for modifications during procedures
Literature Review
SC 3
0016
System must have high hematocrit with excellent RBC
recovery
Hematocrit (Hct) level ~ 60%
RBC recovery ~ 85%
Washout performance
Albumin removal ~ 97%
Heparin removal ~ 99%
Potassium ~ 92%
Fat Removal > 99%
Literature Review
SC 4
0016
System must have easy-to-read color touch screen
Literature Review
SC 5
0016
System must have barcode scanner capability
Literature Review
SC 6
0016
System must be lightweight, portable, on locking casters
Literature Review
SC 7
0016
System must be able to capture and transfer procedure data
Literature Review
SC 8
0016
Specification Requirements:
Weight of device
Voltage Requirement: 100 240 VAC ±10%
Pump speed 0 400 mL/min
Centrifuge speed: Latham bowl: 0 - 2400 rpm
Literature Review
VENDORS ARE REQUIRED TO SITE WHERE IN THEIR LITERATURE THESE SC s ARE REFLECTED..